Voss Capital LP 13D and 13G filings for Rein Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-26 6:46 pm Purchase | 2025-09-24 | 13G | Rein Therapeutics Inc. RNTX | Voss Capital LP | 2,666,532 11.300% | 1,388,676 (+108.67%) | Filing |
| 2025-05-14 8:26 pm Purchase | 2025-05-08 | 13G | Rein Therapeutics Inc. RNTX | Voss Capital LP | 1,277,856 5.600% | 1,277,856 (New Position) | Filing |